🇺🇸 FDA
Patent

US 9308206

Compositions and methods for treating colon cancer

granted A61KA61K31/195A61K31/4188

Quick answer

US patent 9308206 (Compositions and methods for treating colon cancer) held by The Board of Regents of the University of Texas System expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/195, A61K31/4188, A61K31/426, A61K31/4747